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In Brief
Harris et al. demonstrate that an
evolutionarily conserved innate immune
receptor, PGRP-LC, is required for
homeostatic plasticity. A novel, neuronal
function for PGRP-LC highlights a
potential intersection of innate immune
signaling with homeostatic mechanisms
that stabilize neural function throughout
life.
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It is now appreciated that the brain is immunologi-
cally active. Highly conserved innate immune
signaling responds to pathogen invasion and injury
and promotes structural refinement of neural cir-
cuitry. However, it remains generally unknown
whether innate immune signaling has a function dur-
ing the day-to-day regulation of neural function in the
absence of pathogens and irrespective of cellular
damage or developmental change. Here we show
that an innate immune receptor, a member of the
peptidoglycan pattern recognition receptor family
(PGRP-LC), is required for the induction and sus-
tained expression of homeostatic synaptic plasticity.
This receptor functions presynaptically, controlling
the homeostatic modulation of the readily releasable
pool of synaptic vesicles following inhibition of
postsynaptic glutamate receptor function. Thus,
PGRP-LC is a candidate receptor for retrograde,
trans-synaptic signaling, a novel activity for innate
immune signaling and the first known function of a
PGRP-type receptor in the nervous system of any
organism.
INTRODUCTION
The homeostatic modulation of presynaptic neurotransmitter
release has been observed at mammalian central synapses
and at neuromuscular synapses in species ranging from
Drosophila to mouse and human (for review, see Davis and
Mu¨ller, 2015). The homeostatic enhancement of presynaptic
release following inhibition of postsynaptic glutamate receptors
is achieved by an increase in presynaptic calcium influx through
presynaptic CaV2.1 calcium channels and the simultaneous
expansion of the readily releasable pool (RRP) of synaptic vesi-
cles (for review, see Davis and Mu¨ller, 2015). To date, the retro-
grade, trans-synaptic signaling system that initiates these
presynaptic changes following disruption of postsynaptic gluta-
mate receptors remains largely unknown (but see Wang et al.,
2014).NeA large-scale forward genetic screen for homeostatic plas-
ticity genes, using synaptic electrophysiology at the neuromus-
cular junction (NMJ) as the primary assay (Dickman and Davis,
2009; Younger et al., 2013), identified mutations in the PGRP-
LC locus that block presynaptic homeostasis. In Drosophila,
PGRP-LC is the primary receptor that initiates an innate immune
response through the immune deficiency (IMD) pathway (Fig-
ure 1; Royet and Dziarski, 2007). In mammals, there are four
PGRPs including a ‘‘long’’ isoform (PGRP-L or PGlyRP2) that ap-
pears to have both secreted and membrane-associated activity
(Royet and Dziarski, 2007). In mice, the PGlyRP2 protein has two
functions in the innate immune response: a well-documented
extracellular enzymatic (amidase) activity (Royet and Dziarski,
2007) and a pro-inflammatory signaling function that is indepen-
dent of its extracellular enzymatic activity (Saha et al., 2009). As
yet, there are no known functions for PGRPs in the nervous sys-
tem of any organism.RESULTS
PGRP Is Required for the Robust Expression of
Presynaptic Homeostatic Plasticity
Two major isoforms of PGRP-LC are transcribed, PGRP-LCx
and PGRP-LCa (Figure 1B), both of which are known to partic-
ipate in the innate immune response (Choe et al., 2002). Presyn-
aptic homeostasis was quantified (0.4 mM [Ca2+]e) in two inde-
pendent loss-of-function alleles, a deletion of the PGRP-LC
gene locus (PGRPdel; Gottar et al., 2002) that removes both
PGRP isoforms and a nonsense mutation in the PGRP domain
of the PGRP-LCx isoform that results in an isoform-specific,
loss of function allele (PGRP2; Choe et al., 2002) (see Figure 1B).
We demonstrate that application of the glutamate receptor
antagonist PhTx (10–20 mM) decreases mEPSP amplitudes by
50% in all genotypes (Figures 1C–1F; compare light and
dark bars for each genotype, representing the absence []
and presence [+] of PhTx; p < 0.01). In wild-type, we observe
a significant homeostatic increase in quantal content (p <
0.01) that brings EPSP amplitudes back toward the levels
observed in the absence of PhTx (Figures 1D–1F). We then
show, in both PGRP-LC mutant alleles as well as the trans-het-
erozygous allelic combination, that there is no homeostatic
enhancement of quantal content following PhTx application
(Figure 1F; p > 0.5 compare dark and light bars for eachuron 88, 1157–1164, December 16, 2015 ª2015 Elsevier Inc. 1157
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Figure 1. Identification of PGRP-LC as an Innate Immune Receptor Involved in the Rapid Induction and Sustained Expression of Presynaptic
Homeostasis
(A) Diagram of PGRP-LC in different species (PGLYRP 2 in mouse, M.m.; and human, H.s.). Rectangles represent PGRP domains.
(B) Schematic of the PGRP-LC locus showing two alternative splice variants involved in innate immune signaling (PGRP-LCa and PGRP-LCx). The entire coding
region is deleted in PGRPdel. Star denotes a nonsense mutation (PGRP2) truncating the PGRP domain of the PGRP-LCx isoform.
(C) Sample data showing EPSP and mEPSP amplitudes in the absence and presence of PhTx for WT (gray/black respectively) and PGRPdel (light green/dark
green).
(D) Average data for mEPSP amplitude for indicated genotypes in the absence (light gray/light green) and presence of PhTx (black/dark green). PhTx application
reduces amplitudes in all genotypes (p < 0.01).
(E) Average data for EPSP amplitude as in (D) (**p < 0.01).
(F) Average data for quantal content as in (D) (ns; p > 0.05).
(G) Sample data showing EPSC amplitudes as in (C), 3 mM [Ca2+]e.
(H) Average data for mEPSP amplitudes and quantal content following application of PhTx expressed as percent change relative to baseline in the absence of
PhTx for each genotype. Homeostasis is suppressed in PGRPdel compared to wild-type (**p < 0.01) and is blocked in PGRP2 at 3 mM extracellular calcium.
(I) Analysis of PGRPdel, extracellular calcium as indicated. Homeostasis is blocked at 0.3 mM [Ca2+]e (p > 0.3) and 0.7 mM [Ca
2+]e (p > 0.1), and is suppressed at
1.5 (see H) and 3 mM (although statistically significant homeostasis is observed above PGRPdel baseline, p < 0.01).
(J–K) Average data for mEPSP amplitude and quantal contents for indicated genotypes. Data are mean ± SEM for all figures. Student’s t test.genotype) and EPSP amplitudes are dramatically decreased
compared to each genotype in the absence of PhTx (Figure 1E;
p < 0.01). Sample sizes for all experiments are presented in Ta-
ble S1. Thus, PGRP-LC is essential for the rapid induction of
presynaptic homeostasis.
Examination of baseline synaptic transmission reveals that
loss of PGRP-LC has a small, but measurable, effect on baseline
parameters, but completely blocks the rapid induction of presyn-
aptic homeostasis measured at 0.4 mM [Ca2+]e. In both PGRP
del
and PGRP2, we observe small, but statistically significant, de-
creases in spontaneous miniature excitatory postsynaptic po-1158 Neuron 88, 1157–1164, December 16, 2015 ª2015 Elsevier Inctential (mEPSP) amplitude and excitatory postsynaptic potential
(EPSP) amplitude, but no significant change in quantal content
(Figures 1D–1F). When PGRP2 is placed in trans to PGRPdel,
mEPSP amplitudes remain decreased (p < 0.05), EPSP ampli-
tude is unchanged compared to wild-type (p > 0.05) and there
is a small, but statistically significant, increase in quantal content
compared to wild-type (p < 0.05). When mEPSP amplitudes are
plotted as cumulative frequency distributions, the entire distribu-
tion of amplitudes is slightly shifted in the PGRP mutants
compared to wild-type (Figure S1). Finally, we demonstrate
that wild-type and PGRP2 NMJs show statistically similar.
sensitivity to application of EGTA-AM (25 mM for 10 min) (p > 0.5;
data not shown).
We then tested whether loss of PGRP-LC blocks presynaptic
homeostasis induced by a mutation in the GluRIIA subunit of the
postsynaptic glutamate receptor. This mutation is present
throughout the life of the organism and, therefore, tests for the
sustained expression of presynaptic homeostasis. The homeo-
static potentiation of quantal content normally observed in
the GluRIIAmutant background (p < 0.01) is completely blocked
in the GluRIIA; PGRPdel double mutant (Figures 1J and 1K;
p > 0.5). Thus, PGRP-LC is also necessary for the sustained
expression of presynaptic homeostasis.
We next repeated our assays of presynaptic homeostasis at
[Ca2+]e ranging from 0.3 to 3 mM, a 10-fold range of [Ca
2+]e
that encompasses what is believed to be physiological [Ca2+]e
at this synapse. In PGRP2, we find that homeostatic plasticity
is blocked at 0.4mM (Figure 1F) as well as at 3.0mM [Ca2+]e (Fig-
ures 1G and 1H), demonstrating that homeostatic plasticity is
blocked in thePGRP2mutant at all [Ca2+]e. However, we observe
a statistically significant (p < 0.01), homeostatic response in the
PGRP-LC deletion allele at 3 mM [Ca2+]e (Figure 1H), although
the magnitude of this homeostatic response is significantly less
that that observed in wild-type (p < 0.05), indicating that homeo-
static plasticity is not normal in this allele, even at this elevated
extracellular calcium concentration. When we examined two
intervening calcium concentrations, specifically testing the
PGRPdel allele, we find no homeostatic increase in quantal con-
tent at 0.7 mM extracellular calcium (Figure 1I; p > 0.1) and sta-
tistically significant (p < 0.01) homeostatic plasticity at 1.5 mM
extracellular calcium. While it remains unclear why the PGRP2
allele is more severe than PGRPdel, we considered several
issues. We tested the heterozygous PGRP2/+ allele and find no
evidence of a dominant interfering effect since both baseline
release and homeostatic plasticity are normal (Figure S2). It re-
mains possible that enhanced transcription of another, related
innate immune receptor could partially restore signaling in the
PGRPdel gene deletion background, but not when a mutant re-
ceptor isoform is transcribed, as in PGRP2. There are several
PGRP receptors including modulatory and inhibitory receptors
that could mediate this effect (Dziarski, 2004). Regardless, two
conclusions are possible based upon our existing data. First,
deletion of the PGRP gene clearly impairs presynaptic homeo-
stasis and renders it less robust to changes in extracellular cal-
cium, with an unequivocal blockade of homeostatic plasticity
in the range of 0.3–0.7 mM [Ca2+]e. Second, a mutation that spe-
cifically disrupts the PGRP-LCx isoform causes a complete fail-
ure of presynaptic homeostatic plasticity.
PGRP-LCx Functions Neuronally During Presynaptic
Homeostasis
To determine the cell type in which PGRP-LC functions during ho-
meostatic plasticity, we pursued rescue experiments with a
Venus-tagged PGRP-LCx isoform under UAS-control (Figures
2A and 2E–2G). Presynaptic expression of UAS-PGRP-LCx-
Venus fully restores homeostatic potentiation to the PGRPdel
mutant (0.4mM[Ca2+]e),whereaspostsynapticmuscleexpression
does not (Figure 2G). We note that muscle-specific PGRP-LCx
expression in the PGRPmutant background causes a substantialNereduction in bothmEPSP and EPSP amplitudes. To control for the
possibility thatmuscle-specificexpressionmightdominantly inter-
fere with presynaptic homeostasis, we overexpressed PGRP-
LCx-Venus in wild-type muscle. We document a similar decrease
in baseline mEPSP and EPSP amplitudes compared to wild-type
(Figures 2H and 2I) that can be attributed, in part, to diminished
input resistance and a depolarized resting potential (Figures 2K
and 2L). Importantly, homeostatic plasticity is fully expressed (Fig-
ure 2J). Thus, we can conclude thatmuscle-specific expression of
PGRP-LCx fails to rescuehomeostatic plasticity.Wealsonote that
motoneuron-specific expression of PGRP-LCx induces a modest
increase in EPSP amplitude (p < 0.01) and a trend toward
increasedmEPSP amplitude (p = 0.08). This activity could reason-
ably contribute to the rescue of baseline defects in mEPSP and
EPSP amplitudes when PGRP-LCx-Venus is expressed neuro-
nally in the PGRP mutant background (compare Figures 2E and
2F with Figures 1D and 1E). But, the observed rescue of homeo-
static plasticity whenPGRP-LCx-Venus is expressed inmotoneu-
rons (Figure 2G) clearly occurs over and above any minor effects
on baseline transmission. Therefore, we conclude that PGRP-
LCx isoform expression in motoneurons supports robust homeo-
static plasticity. This complements the observed necessity of the
PGRP-LCx isoform, demonstratedby the elimination of presynap-
tic homeostasis in the PGRP2 mutant.
Next, we perform the converse experiment using RNAi to
deplete PGRP expression specifically in neurons or muscle (Fig-
ure 2). We demonstrate that expression of UAS-PGRP-LC RNAi
in neurons blocks homeostatic plasticity, while expression in
muscle does not (Figures 2A–2D). Finally, we find that PGRP-
LC mRNA is weakly, but endogenously expressed in motoneu-
rons, determined by custom micro-array analysis of mRNA
expression inFACS isolated,GFP-expressingmotoneurons (Par-
rish et al., 2014; data not shown). Taken together, these data are
consistent with the conclusion that PGRP-LC, and PGRP-LCx in
particular, functions presynaptically to enable homeostatic plas-
ticity. These experiments also demonstrate that failed presynap-
tic homeostasis following loss of PGRP-LC cannot be attributed
to the systemic effects associatedwith impaired innate immunity.
More specifically, neuronal expression ofPGRP-LC-RNAi blocks
homeostatic plasticity even though innate immune signaling
throughout the rest of the organism is unaltered. In addition,
conversely, in our rescue experiments, innate immune signaling
should be compromised everywhere except the nervous system
and homeostatic plasticity is fully functional.
PGRP-LC Traffics to the Nerve Terminal and Does Not
Alter Synaptic Growth
We next addressed where PGRP-LC resides within motoneu-
rons. Analysis of PGRP-LCx-Venus distribution in motoneurons
demonstrates that the Venus-tagged receptor trafficks to the
presynaptic nerve terminal. We observe PGRP-LCx-Venus
puncta distributed throughout the presynaptic terminal (Fig-
ure 3A). Co-staining with the active zone marker Bruchpilot
(BRP) reveals that the receptors are not present at the active
zone. These data suggest that PGRP-LCx is a presynaptic re-
ceptor, consistent with a required function during the rapid in-
duction of presynaptic homeostasis, which occurs locally at
the isolated NMJ.uron 88, 1157–1164, December 16, 2015 ª2015 Elsevier Inc. 1159
Figure 2. PGRP Is Required in Motoneurons for Presynaptic Homeostasis
(A) Sample data showing EPSP and mEPSP waveforms ± PhTx for the indicated genotypes.
(B) Average mEPSP amplitude when PGRP-RNAi is expressed neuronally (elaV-GAL4) or in muscle (BG57-GAL4), ± PhTx as indicated. PhTx application reduces
amplitudes in all genotypes (p < 0.01).
(C) Average EPSP amplitude as in B. (**p < 0.01).
(D) Average percent change in mEPSP amplitude and quantal content in PhTx compared to baseline for the indicated conditions.
(E) Average mEPSP amplitude for indicated rescue experiments as follows: Neural rescue = elaV-GAL4 expression of UAS-PGRP-LCx in the PGRPdel mutant;
motoneuron rescue = OK371-GAL4; muscle rescue = MHC-GAL4. PhTx application reduces amplitudes in all genotypes (p < 0.01).
(F) Average EPSP amplitude as in (E).
(G) Average percent change in mEPSP amplitude and quantal content as in (D). When UAS-PGRP-LCx is expressed presynaptically, homeostasis is rescued
(p < 0.05). Expression in muscle does not (p > 0.05).
(H) Average mEPSP amplitude for expression of UAS-PGRP-LCx in a wild-type background, drivers as indicated in (E).
(I) Average EPSP amplitudes for genotypes as in (H).
(J) Average percent change in mEPSP amplitude and quantal content for genotypes as in (H). Significant homeostasis is observed in all conditions (p < 0.01).
(K) Muscle input resistance for the indicated genotypes (**p < 0.01).
(L) Muscle resting membrane potential. Average RMP (**p < 0.01). Student’s t test.An analysis of synapse morphology reveals a grossly normal
NMJ anatomy. There are no significant changes in synaptic bou-
ton number or active zone number that could account for the
change in homeostatic plasticity (Figure 3B). Active zone number
is quantified as the number of Bruchpilot (Brp) puncta at theNMJ,1160 Neuron 88, 1157–1164, December 16, 2015 ª2015 Elsevier Incconsistent with previous studies (Mu¨ller et al., 2012). Similarly,
there are nomajor deficits in the abundance of essential synaptic
vesicle proteins. Indeed, there is a slight increase in the abun-
dance of Cysteine String Protein (CSP) and Synaptotagmin1
(Syt1) (see Figure S3). Thus, the growth and general organization.
Figure 3. PGRP-LC-Venus Localizes to the
Presynaptic Terminal
(A) Left: Image in of an NMJ in which UAS-PGRP-
LCx-Venus was expressed using Ok371-Gal4. The
NMJ was co-stained with HRP (red) and anti-GFP
(green). Magnified and rotated images (below)
indicate the membrane-proximal localization of
PGRP-LCx-Venus. Right: NMJ expressing UAS-
PGRP-LCx-Venus as in (A). The NMJ was co-
stained with the presynaptic active zone marker
Brp (red) and anti-Venus (green).
(B) WT NMJ at muscle 4 (left) co-stained with the
presynaptic active zone marker Brp (top, green)
and the postsynaptic marker Dlg (middle, red).
Merge at bottom.
(C) Quantification of bouton number per NMJ at
muscle 4.
(D) Brp puncta per bouton at muscle 4.
(E and F) Quantification of average staining in-
tensities for anti-Syt1 and anti-CSP (**p < 0.01).
(G) Representative active zone images. Scale bar
represents 150 nm.
(H–K) Quantification of vesicle diameter per active
zone (AZ) (H), average vesicle distance from T-bar
base (see text) (I), average vesicle number per
active zonewithin a 150 nm radius of T-bar base (J),
average AZ length (K). Student’s t test with Bon-
ferroni correction.of the NMJ are not adversely affected by the absence of an
essential innate immune receptor.
Finally,weexamined synaptic ultrastructure. Active zoneswere
identified by the presence of a presynaptic ‘‘T-bar’’ within a zone
of pre- and postsynaptic electron dense membrane. For each
active zone, we identified those synaptic vesicles that reside
within 150 nm of the center of the pedestal of the T-bar (centroid),
where presynaptic voltage gated calcium channels reside. For
this population of vesicles, at each active zone, we quantified
average vesicle diameter, average vesicle number, average
vesicle distance from the T-bar centroid and, finally, the two-Neuron 88, 1157–1164, Dedimensional length of the active zone,
defined as the continuous electron density
on either side of the T-bar. There is no sig-
nificant difference in any of these parame-
ters comparing wild-type with the PGRPdel
or the PGRP2 mutants. We conclude that
loss of PGRP does not impair the integrity
or organization of the active zone. By
extension, the failure of presynaptic ho-
meostatic plasticity is not a secondary
consequence of impaired active zone or-
ganization, vesicle number, or vesicle dis-
tance from the T-bar (Figures 3G–3K).
PGRP Controls the Homeostatic
Modulation of the Readily
Releasable Vesicle Pool
The homeostatic modulation of presynap-
tic neurotransmitter release has beendemonstrated to require potentiation of the readily releasable
pool (RRP) of presynaptic vesicles (Davis and Mu¨ller, 2015).
We define the RRP as the number of vesicles released during a
brief (500 ms) high frequency stimulus train at elevated extracel-
lular calcium concentrations (3 mM [Ca2+]e), according to pub-
lishedmethods (Schneggenburger et al., 1999). For this analysis,
we focused on the PGRP2 mutation because it blocks homeo-
static plasticity at 3 mM [Ca2+]e. At this [Ca
2+]e PGRP
2 mutants
show a small decrease in mEPSP and cumulative EPSC ampli-
tudes (Figures 4A–4C), but no significant difference in the base-
line RRP (WT = 2,370 ± 227; PGRP2 = 2,236 ± 190; p > 0.3),cember 16, 2015 ª2015 Elsevier Inc. 1161
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Figure 4. Loss of PGRP-LC Blocks the Homeostatic Expansion of the Readily Releasable Vesicle Pool
(A) Example EPSC traces (top) and cumulative EPSC amplitudes (bottom)minus and plus PhTx forWT andPGRP2. Experiment used 60-Hz stimulation (30 stimuli)
in 3 mM [Ca2+]e. The line fit to cumulative EPSC data that was back-extrapolated to time 0 is shown in red.
(B) Average data for mEPSP amplitudes for the indicated experiments. PhTx application reduces amplitudes in all genotypes (p < 0.01).
(C) Cumulative EPSC amplitudes as in (B) (*p < 0.05; **p < 0.01).
(D) Average percent change inmEPSP amplitude and RRP size in PhTx. There is not a significant PhTx-dependent increase in RRP in thePGRP2mutant (p > 0.05).
The percent change comparing WT and PGRP2 is significantly different (p < 0.05).
(E) Average percent change in mEPSP and quantal content caused by PhTx application to the indicated genotypes. PGRPdel/+ heterozygous mutants have
normal presynaptic homeostasis compared to wild-type (p > 0.2). There is significant presynaptic homeostasis in rim/+ (± PhTx, p < 0.01) but a slight suppression
of presynaptic homeostasis in rim/+ compared to wild-type (p < 0.05). The double heterozygous condition PGRPdel/+ ; rim/+ completely blocks homeostatic
plasticity (p > 0.5).
(F) Average changes as in (E). Significant presynaptic homeostasis is observed in PGRP2/+ and dmp/+ heterozygous animals (p < 0.05). No significant ho-
meostasis is observed in the double heterozygous condition (p > 0.05).
(G) Example EPSP traces minus and plus PhTx for WT and DC rescue at 0.3mM [Ca2+]e. DC denotes expression of UAS-PGRP truncated transgene, see
Supplemental Experimental Procedures.
(H) mEPSP amplitudes as in (B), all PhTx changes are significant (p < 0.01).
(I) Average data for EPSP amplitudes in the indicated experiments (**p < 0.01).
(J) Average data for quantal content in the indicated genotypes.
(K) Average changes as in (E). Student’s t test.consistent with quantification of baseline neurotransmission at a
ten-fold lower [Ca2+]e (Figures 1D–1F). Following application of
PhTx, there is a statistically significant, homeostatic potentiation
of the RRP inwild-type (Figure 4D; p < 0.01). However, there is no
significant increase of the RRP in the PGRP2mutant (p > 0.1). We
conclude that PGRP-LC is necessary for the homeostatic expan-
sion of the RRP. We also note that the failure to expand the RRP
does not correlate with altered vesicle number or distribution
(Figure 3).1162 Neuron 88, 1157–1164, December 16, 2015 ª2015 Elsevier IncWe quantified two additional parameters based on delivery of
stimulus trains to the NMJ (Figure 4A): (1) short-term synaptic
depression during the stimulus train, and (2) an estimate of
release probability at the onset of the stimulus train (Ptrain; esti-
mated by dividing the first EPSC amplitude in the stimulus train
by cumulative EPSC) (Thanawala and Regehr, 2013). Short-
term depression was calculated as the percent change in
EPSC amplitude comparing EPSC1 and EPSC4 of a stimulus
train. There was no difference comparing wild-type in the.
presence or absence of PhTx with PGRP2 in the presence or
absence of PhTx (p > 0.05; WT (PhTx) = 59.7 ± 1.7%,
WT(+PhTx) = 54.6 ± 1.5%, PGRP2(PhTx) = 57.8 ± 2.4%,
PGRP2 (+PhTx) = 55.0 ± 2.3%). There is a small, but significant,
2.7% increase in Ptrain comparing wild-type and PGRP
2 (p <
0.05). However, application of PhTx does not alter Ptrain in either
genotype (wt = 0.25 ± 0.07; wt+PhTx = 0.26 ± 0.09; PGRP2 =
0.27 ± 0.01; PGRP2 + PhTx = 0.28 ± 0.01). These data argue
that the primary consequence of the PGRP2 mutation is not a
change in presynaptic release probability, but rather the elimina-
tion of a homeostatic expansion of the RRP.
Finally, we sought additional genetic evidence that PGRP acts
in concert with other established mechanisms that are respon-
sible for the homeostatic potentiation of the RRP during presyn-
aptic homeostasis. It was previously demonstrated that the
homeostatic potentiation of the RRP requires the presence of
the active-zone associated scaffold RIM (Rab3 Interacting Mole-
cule) (Davis and Mu¨ller, 2015). Therefore, we tested whether
PGRPdel interacts, genetically, with a null mutation in rim. The
heterozygous mutation in PGRP-LC (PGRPdel/+) shows robust
homeostatic potentiation (Figure 4E). We then examined a het-
erozygous null mutation in rim (rim103/+) and, again, document
robust presynaptic homeostasis, although somewhat less pro-
nounced compared to that observed in PGRPdel alone (Fig-
ure 4E). But, when we examine the double heterozygous mutant
combination we find a block of presynaptic homeostasis (p >
0.05; Figure 4E). This result underscores the likelihood PGRP is
required for the RIM-dependent modulation of the RRP during
presynaptic homeostasis. It is possible that RIM could be a
target of signaling downstream of PGRP-LCx activation, but
this remains speculative without additional information about
the signaling system that acts downstream of PGRP-LC within
the presynaptic terminal.
PGRP Interacts Genetically with Multiplexin/Endostatin
In innate immunity, PGRP-LCx recognizes a peptidoglycan
sequence presented by invading bacteria. One interesting possi-
bility is that PGRP-LCx might recognize molecular patterns
caused by the cleavage of extracellular matrix proteins at the
nerve terminal. Regulated proteolysis of synaptic proteins is
becoming increasingly apparent as a mode of inter-cellular
signaling (Peixoto et al., 2012). We recently demonstrated that
Endostatin, a small peptide that is released following proteolytic
cleavage of the Drosophila Collagen VIII homolog Multiplexin, is
necessary for presynaptic homeostasis (Wang et al., 2014).
Therefore, we tested whether PGRP interacts, genetically, with
a strong loss of function mutation in multiplexin. The heterozy-
gous mutation in PGRP-LC (PGRP2/+) shows robust homeostat-
ic potentiation, as does a heterozygous mutation in multiplexin
(dmpf07253/+) (Figure 4F). But, when we examine the double het-
erozygous mutant combination we find a complete block of pre-
synaptic homeostasis (p > 0.05) (Figure 4F). These data are
consistent with a model in which Endostatin could function as
a ligand for PGRP, but additional work is necessary to prove
that this interaction occurs biochemically.
If PGRP-LC functions as a receptor for intercellular signaling
necessary for presynaptic homeostasis, then expression of
PGRP-LC lacking the extracellular PGRP domain (termedNePGRPDC ) should fail to rescue presynaptic homeostasis in the
PGRPdel mutant background. We generated a Venus tagged
PGRP-LC deletion transgene (UAS-PGRPDC-Venus), modeling
it after a similarly truncated receptor that was previously used
to study innate immunity (Choe et al., 2005). First, we document
that neuronally expressed UAS-PGRPDC-Venus localizes to the
presynaptic terminal (Figure S4). Then we show that UAS-
PGRPDC-Venus fails to rescue presynaptic homeostatic plas-
ticity (Figures 4G–4K). There is no effect of UAS-PGRPDC-Venus
expression on baseline transmission and homeostatic plasticity
remains blocked in the PGRPdel mutant background. Impor-
tantly, the UAS-PGRPDC-Venus transgene is similar to the pre-
dicted protein truncation caused by the PGRP2 mutation, which
resides at the start of the PGRP domain. This result, therefore,
further validates the functional blockade of presynaptic homeo-
stasis observed in the PGRP2 mutant.
DISCUSSION
Innate immune signaling has been found to participate in neural
development and disease including a role for the C1q compo-
nent of the complement cascade (Stevens et al., 2007), Toll-
like receptor signaling (Okun et al., 2011), and tumor necrosis
factor signaling (Stellwagen and Malenka, 2006). In these exam-
ples, however, the innate immune response is induced within mi-
croglia or astrocytes. Far less clear is the role of innate immune
signalingwithin neurons, either centrally or peripherally, although
there are clear examples of downstream signaling components
such as Rel and NFkB having important functions during learning
related neural plasticity (Meffert et al., 2003; Ahn et al., 2008).
Here we place the innate immune receptor, PGRP-LC at the pre-
synaptic terminal of Drosophila motoneurons and demonstrate
that this receptor is essential for robust presynaptic homeostatic
plasticity. We speculate, based on our data, that PGRP-LC could
function as a receptor for the long-sought retrograde signal that
mediates homeostatic signaling from muscle to nerve.
A Model for Innate Immune Signaling: PGRP-LC as a
Feed-Forward Signaling Switch for Homeostatic
Plasticity
A distinguishing feature of presynaptic homeostatic plasticity is
that it can be both rapidly induced and sustained for prolonged
periods (Davis and Mu¨ller, 2015). It is possible that innate im-
mune signaling activity is adjusted to fit the requirements of pre-
synaptic homeostasis in motoneurons. This would be consistent
with the established diversity of innate immune signaling func-
tions during development such as dorso-ventral patterning (An-
derson et al., 1985). Alternatively, the induction of innate immune
signaling might serve a unique function during presynaptic ho-
meostasis. Many homeostatic signaling systems incorporate
feed-forward signaling elements (Davis and Mu¨ller, 2015). By
analogy, PGRP-LCx could function as a feed-forward signaling
receptor that acts more like a ‘‘switch’’ to enable presynaptic ho-
meostasis in the nerve terminal. The accuracy of the homeostatic
response would be determined by other signaling elements. In
favor of this idea, the induction of innate immune signaling is
rapid, occurring in seconds to minutes (Sto¨ven et al., 2000),
and can be maintained for the duration of an inducing stimulus,uron 88, 1157–1164, December 16, 2015 ª2015 Elsevier Inc. 1163
consistent with recent evidence that presynaptic homeostasis is
rapidly and continually induced at synapses in the presence of a
persistent postsynaptic perturbation (Younger et al., 2013).
Finally, it remains formally possible that PGRP-dependent
signaling is a permissive signal that allows expression presynap-
tic homeostasis (see supplemental discussion).
EXPERIMENTAL PROCEDURES
See the Supplemental Experimental Procedures for complete anatomical,
electrophysiological, and genetic methods.
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